Nitrofurantoin Activase Pharmaceuticals

Nitrofurantoin, the active ingredient in Nitrofurantoin Activase Pharmaceuticals, is a nitrofuran antibiotic presented as an oral tablet for oral use. It is employed to treat uncomplicated urinary tract infections, including cystitis, in adult patients. The drug exerts bactericidal activity against common urinary pathogens such as Escherichia coli and Staphylococcus saprophyticus, providing rapid symptom relief.

GNH USA supplies Nitrofurantoin Activase Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery, regulatory compliance, and support for procurement teams across multiple regions.

Nitrofurantoin is a nitrofuran antibiotic used to treat infections of the urinary tract.

- Uncomplicated urinary tract infection: eliminates bacterial growth in the bladder, relieving dysuria, frequency and urgency. - Cystitis: resolves bladder inflammation caused by susceptible uropathogens, leading to clinical cure. - Prophylaxis of recurrent urinary tract infection: may be prescribed in selected patients to reduce the frequency of future episodes.

Adverse reactions may occur with nitrofurantoin therapy.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, often transient. - Headache: mild cranial discomfort. - Rash: skin redness or itching.

Serious or Rare Side Effects: - Pulmonary toxicity: interstitial lung disease or acute pneumonitis. - Hepatic injury: jaundice or elevated liver enzymes. - Hemolytic anemia in G6PD‑deficient patients. - Severe allergic reaction: anaphylaxis or angioedema. - Peripheral neuropathy: tingling or numbness in extremities.

Before prescribing nitrofurantoin, consider patient‑specific factors and safety measures.

- Assess renal function: avoid or adjust use in patients with creatinine clearance <60 mL/min. - Avoid in known hypersensitivity: discontinue if allergic reactions develop. - Monitor for pulmonary symptoms: discontinue if cough, dyspnea or fever appear. - Use with caution in G6PD deficiency: risk of hemolysis. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nitrofurantoin may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: decrease nitrofurantoin absorption. - Probenecid: reduces renal excretion, increasing plasma levels. - Warfarin: may enhance anticoagulant effect, increasing INR.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive effectiveness. - Diuretics: increase risk of crystalluria and renal impairment. - NSAIDs: may compound renal toxicity, especially in volume‑depleted patients.